PL3823960T3 - Izoksazol jako agonisty receptora fxr - Google Patents
Izoksazol jako agonisty receptora fxrInfo
- Publication number
- PL3823960T3 PL3823960T3 PL19769877.2T PL19769877T PL3823960T3 PL 3823960 T3 PL3823960 T3 PL 3823960T3 PL 19769877 T PL19769877 T PL 19769877T PL 3823960 T3 PL3823960 T3 PL 3823960T3
- Authority
- PL
- Poland
- Prior art keywords
- isoxazole
- receptor agonists
- fxr receptor
- fxr
- agonists
- Prior art date
Links
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000007265A IT201800007265A1 (it) | 2018-07-17 | 2018-07-17 | Isossazoli come agonisti del recettore fxr |
| PCT/IB2019/056114 WO2020016801A1 (en) | 2018-07-17 | 2019-07-17 | Isoxazole as fxr receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3823960T3 true PL3823960T3 (pl) | 2023-03-20 |
Family
ID=63762897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19769877.2T PL3823960T3 (pl) | 2018-07-17 | 2019-07-17 | Izoksazol jako agonisty receptora fxr |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11332450B2 (pl) |
| EP (1) | EP3823960B1 (pl) |
| JP (1) | JP7629846B2 (pl) |
| KR (1) | KR20210045390A (pl) |
| CN (1) | CN112424173A (pl) |
| BR (1) | BR112021000913A2 (pl) |
| CA (1) | CA3106309A1 (pl) |
| DK (1) | DK3823960T3 (pl) |
| ES (1) | ES2932290T3 (pl) |
| FI (1) | FI3823960T3 (pl) |
| HR (1) | HRP20221450T1 (pl) |
| HU (1) | HUE060708T2 (pl) |
| IT (1) | IT201800007265A1 (pl) |
| LT (1) | LT3823960T (pl) |
| MX (1) | MX2021000475A (pl) |
| PL (1) | PL3823960T3 (pl) |
| PT (1) | PT3823960T (pl) |
| RS (1) | RS63854B1 (pl) |
| SI (1) | SI3823960T1 (pl) |
| SM (1) | SMT202200485T1 (pl) |
| WO (1) | WO2020016801A1 (pl) |
| ZA (1) | ZA202100513B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116925059A (zh) * | 2022-03-31 | 2023-10-24 | 广东药科大学 | 一类新型异恶唑类fxr激动剂、其制备方法及其作为药物的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE381542T1 (de) * | 2001-08-13 | 2008-01-15 | Phenex Pharmaceuticals Ag | Nr1h4-kern-rezeptor-bindende verbindungen |
| JP2006515838A (ja) | 2002-11-22 | 2006-06-08 | スミスクライン ビーチャム コーポレーション | ファルネソイドｘ受容体アゴニスト |
| US8106077B2 (en) | 2006-05-24 | 2012-01-31 | Eli Lilly And Company | Compounds and methods for modulating FXR |
| EP1894924A1 (en) * | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
| CA2690406A1 (en) | 2007-07-02 | 2009-01-08 | Glaxosmithkline Llc | Farnesoid x receptor agonists |
| WO2012087520A1 (en) * | 2010-12-20 | 2012-06-28 | Irm Llc | Compositions and methods for modulating farnesoid x receptors |
| WO2017189663A1 (en) * | 2016-04-26 | 2017-11-02 | Enanta Pharmaceuticals, Inc. | Isoxazole derivatives as fxr agonists and methods of use thereof |
| WO2017201155A1 (en) * | 2016-05-18 | 2017-11-23 | Enanta Pharmaceuticals, Inc. | lSOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF |
| US10144729B2 (en) * | 2016-05-18 | 2018-12-04 | Enanta Pharmaceuticals, Inc. | Isoxazole analogs as FXR agonists and methods of use thereof |
-
2018
- 2018-07-17 IT IT102018000007265A patent/IT201800007265A1/it unknown
-
2019
- 2019-07-17 MX MX2021000475A patent/MX2021000475A/es unknown
- 2019-07-17 WO PCT/IB2019/056114 patent/WO2020016801A1/en not_active Ceased
- 2019-07-17 DK DK19769877.2T patent/DK3823960T3/da active
- 2019-07-17 CN CN201980048015.6A patent/CN112424173A/zh active Pending
- 2019-07-17 HR HRP20221450TT patent/HRP20221450T1/hr unknown
- 2019-07-17 CA CA3106309A patent/CA3106309A1/en active Pending
- 2019-07-17 ES ES19769877T patent/ES2932290T3/es active Active
- 2019-07-17 BR BR112021000913-2A patent/BR112021000913A2/pt unknown
- 2019-07-17 JP JP2021502996A patent/JP7629846B2/ja active Active
- 2019-07-17 RS RS20221101A patent/RS63854B1/sr unknown
- 2019-07-17 PT PT197698772T patent/PT3823960T/pt unknown
- 2019-07-17 FI FIEP19769877.2T patent/FI3823960T3/fi active
- 2019-07-17 SM SM20220485T patent/SMT202200485T1/it unknown
- 2019-07-17 US US17/260,596 patent/US11332450B2/en active Active
- 2019-07-17 EP EP19769877.2A patent/EP3823960B1/en active Active
- 2019-07-17 HU HUE19769877A patent/HUE060708T2/hu unknown
- 2019-07-17 LT LTEPPCT/IB2019/056114T patent/LT3823960T/lt unknown
- 2019-07-17 PL PL19769877.2T patent/PL3823960T3/pl unknown
- 2019-07-17 KR KR1020217003122A patent/KR20210045390A/ko not_active Ceased
- 2019-07-17 SI SI201930388T patent/SI3823960T1/sl unknown
-
2021
- 2021-01-25 ZA ZA2021/00513A patent/ZA202100513B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3823960T (lt) | 2022-12-27 |
| DK3823960T3 (da) | 2022-12-05 |
| HUE060708T2 (hu) | 2023-04-28 |
| JP2021530535A (ja) | 2021-11-11 |
| SI3823960T1 (sl) | 2023-04-28 |
| KR20210045390A (ko) | 2021-04-26 |
| IT201800007265A1 (it) | 2020-01-17 |
| EP3823960A1 (en) | 2021-05-26 |
| CN112424173A (zh) | 2021-02-26 |
| FI3823960T3 (fi) | 2022-12-15 |
| PT3823960T (pt) | 2022-12-07 |
| ES2932290T3 (es) | 2023-01-17 |
| BR112021000913A2 (pt) | 2021-04-13 |
| US11332450B2 (en) | 2022-05-17 |
| ZA202100513B (en) | 2022-07-27 |
| CA3106309A1 (en) | 2020-01-23 |
| EP3823960B1 (en) | 2022-09-14 |
| SMT202200485T1 (it) | 2023-01-13 |
| WO2020016801A1 (en) | 2020-01-23 |
| MX2021000475A (es) | 2021-06-08 |
| HRP20221450T1 (hr) | 2023-03-31 |
| US20210269409A1 (en) | 2021-09-02 |
| RS63854B1 (sr) | 2023-01-31 |
| JP7629846B2 (ja) | 2025-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL260784B (en) | Methods of using fxr agonists | |
| IL261036A (en) | Methods of using fxr agonists | |
| IL270971A (en) | Antibody against the 1-IGF receptor | |
| IL267288B (en) | glp-1 receptor agonists and their use | |
| DK3762380T3 (da) | Phenylpyrrolidinon-formylpeptid-2-receptoragonister | |
| ZA201802371B (en) | Glucagon receptor agonists | |
| IL261021A (en) | Methods for using fxr agonists | |
| IL268426A (en) | Combination of ppar agonist with fxr agonist | |
| ZA201906541B (en) | Isoxazole derivatives as nuclear receptor agonists and uses thereof | |
| IL247081B (en) | Thiazole or oxazole are converted p2x7 receptor antagonists | |
| IL264628A (en) | Combination of fxr agonists | |
| GB201619637D0 (en) | C3a receptor agonists | |
| ZA202100513B (en) | Isoxazole as fxr receptor agonists | |
| GB201817943D0 (en) | Galanin-2 receptor agonists | |
| HK40039646A (en) | Synthetic rig-i-like receptor agonists | |
| HK40003739A (en) | Combination of fxr agonists |